Abstract
Get full access to this article
View all access options for this article.
References
1.Office of the Press Secretary , The White House . www.whitehouse.gov/the-press-office/2016/02/01/fact-sheet-investing-national-cancer-moonshot
2.National Cell Manufacturing Consortium
http://cellmanufacturingusa.org/road-map
3.NIST CAR-T Biomanufacturing Symposium
https://www.ibbr.umd.edu/NISTCART
4.Regulatory considerations for manufacturing and testing of investigational chimeric antigen receptor (CAR) T-cell products
https://www.ibbr.umd.edu/sites/default/files/public_page/Xiaobin%20Victor%20Lu_FDA.pdf
5.NIST Workshop : Strategies to Achieve Measurement Assurance for Cell Therapy Products . http://www.nist.gov/mml/bbd/biomaterials/measurement-assurance-for-cell-therapy-products.cfm
6.
Simon
CG
Jr.
,
Lin-Gibson
S
,
Elliott
JT
,
Sarkar
S
,
Plant
AL
2016 ) Strategies for achieving measurement assurance for cell therapy products . Stem Cells Translational Medicine , 5 , 705 –708 .
7.NIST Genome Editing Standards Workshop
http://www.nist.gov/mml/bbd/genes.cfm
8.U.S. TAG for ISO/TC276: Biotechnology
http://www.nist.gov/mml/bbd/iso.cfm